Related Experiment Video
Updated: Jun 10, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains
Nicolas Reynoird1, Brian E Schwartz, Manuela Delvecchio
1INSERM, U823, Université Joseph Fourier-Grenoble 1, Institut Albert Bonniot, Grenoble, France.
Abstract:
In a subset of poorly differentiated and highly aggressive carcinoma, a chromosomal translocation, t(15;19)(q13;p13), results in an in-frame fusion of the double bromodomain protein, BRD4, with a testis-specific protein of unknown function, NUT (nuclear protein in testis). In this study, we show that, after binding to acetylated chromatin through BRD4 bromodomains, the NUT moiety of the fusion protein strongly interacts with and recruits p300, stimulates its catalytic activity, initiating cycles of BRD4-NUT/p300 recruitment and creating transcriptionally inactive hyperacetylated chromatin domains. Using a patient-derived cell line, we show that p300 sequestration into the BRD4-NUT foci is the principal oncogenic mechanism leading to p53 inactivation. Knockdown of BRD4-NUT released p300 and restored p53-dependent regulatory mechanisms leading to cell differentiation and apoptosis. This study demonstrates how the off-context activity of a testis-specific factor could markedly alter vital cellular functions and significantly contribute to malignant cell transformation.
Insights
A chromosomal translocation creates a BRD4-NUT fusion protein that drives aggressive cancers by hijacking p300, leading to p53 inactivation. Restoring p300 function triggers cancer cell death.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- A specific chromosomal translocation, t(15;19), generates the BRD4-NUT fusion oncogene in aggressive carcinomas.
- The fusion protein involves BRD4, a double bromodomain protein, and NUT (nuclear protein in testis), a testis-specific protein.
Purpose of the Study:
- To elucidate the oncogenic mechanism of the BRD4-NUT fusion protein.
- To investigate the role of p300 and p53 in BRD4-NUT-driven tumorigenesis.
Main Methods:
- Utilized a patient-derived cell line harboring the BRD4-NUT fusion.
- Performed knockdown experiments to assess the functional impact of BRD4-NUT.
- Investigated protein-protein interactions and chromatin modifications.
Main Results:
- BRD4-NUT recruits and hyperactivates p300, leading to transcriptionally inactive chromatin domains.
- p300 sequestration by BRD4-NUT causes p53 inactivation, a key oncogenic event.
- BRD4-NUT knockdown restored p300 and p53 activity, inducing cell differentiation and apoptosis.
Conclusions:
- The aberrant activity of the testis-specific NUT protein in the BRD4-NUT fusion drives malignant transformation.
- Targeting BRD4-NUT or restoring p300/p53 function presents potential therapeutic strategies for NUT-midline carcinomas.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Co-activators and Co-repressors
Anaphase Promoting Complex
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...

